The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayashi, S.
Right arrow Articles by Cohen, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, S.
Right arrow Articles by Cohen, A. B.

The Journal of Immunology, Vol 154, Issue 2 814-824, Copyright © 1995 by American Association of Immunologists


ARTICLES

Synthetic hexa- and heptapeptides that inhibit IL-8 from binding to and activating human blood neutrophils

S Hayashi, A Kurdowska, EJ Miller, ME Albright, BE Girten and AB Cohen
Department of Biochemistry, University of Texas Health Center, Tyler 75710.

IL-8 is a member of the chemokine alpha subfamily that activates and is chemotactic for neutrophils. In these studies, we have synthesized and characterized a hexapeptide inhibitor of IL-8. This peptide, with an acetylated amino terminus and an amidated carboxyl terminus (Ac-RRWWCR- NH2), inhibited the specific binding of 125I-IL-8 to neutrophils. The inhibition was biphasic and apparent Ki was estimated to be approximately 2.7 microM and 13 microM for two different IL-8 binding sites. The peptide inhibited neutrophil chemotaxis, beta-glucuronidase release from neutrophils, and rabbit skin edema induced by IL-8 with an EC50 of 90 microM, 0.8 microM, respectively. Ac-RRWWCR-NH2 also suppressed the binding of macrophage inflammatory protein (MIP) 2 beta to neutrophils. However, it did not inhibit the binding of MIP-1 alpha, C5a, or leukotriene B4 to neutrophils, chemotaxis induced by FMLP, or beta-glucuronidase release induced by FMLP, C5a, or leukotriene B4. Additional peptides were analyzed to identify a better inhibitor. Inhibition of binding by Ac-rrwwcrc-NH2 synthesized with all D-amino acids was almost four times more potent than Ac-RRWWCR-NH2. Small peptide homologues of the amino-terminal end of IL-8 failed to inhibit IL-8 binding to neutrophils. These studies have identified several peptides that significantly inhibit IL-8 function. Because IL-8 seems to be an important inflammatory mediator of several human illnesses, these peptides may have pharmacologic potential.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Lin, H. Yang, T. Sakuragi, M. Hu, L. L. Mantell, S. Hayashi, Y. Al-Abed, K. J. Tracey, L. Ulloa, and E. J. Miller
{alpha}-Chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis
Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L583 - L590.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. L. Lomas-Neira, C.-S. Chung, P. S. Grutkoski, E. J. Miller, and A. Ayala
CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice
J. Leukoc. Biol., July 1, 2004; 76(1): 58 - 64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
U. Maus, K. von Grote, W. A. Kuziel, M. Mack, E. J. Miller, J. Cihak, M. Stangassinger, R. Maus, D. Schlondorff, W. Seeger, et al.
The Role of CC Chemokine Receptor 2 in Alveolar Monocyte and Neutrophil Immigration in Intact Mice
Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 268 - 273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Jaye, H. A. Edens, L. Mazzucchelli, and C. A. Parkos
Novel G Protein-Coupled Responses in Leukocytes Elicited by a Chemotactic Bacteriophage Displaying a Cell Type-Selective Binding Peptide
J. Immunol., June 15, 2001; 166(12): 7250 - 7259.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-S. Bae, H. Bae, Y. Kim, T. G. Lee, P.-G. Suh, and S. H. Ryu
Identification of novel chemoattractant peptides for human leukocytes
Blood, May 1, 2001; 97(9): 2854 - 2862.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. M. Murphy, M. Baggiolini, I. F. Charo, C. A. Hebert, R. Horuk, K. Matsushima, L. H. Miller, J. J. Oppenheim, and C. A. Power
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Pharmacol. Rev., March 1, 2000; 52(1): 145 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Fujisawa, S. Hayashi, A. Kurdowska, J. M. Noble, K. Naitoh, and E. J. Miller
Staphylococcal Enterotoxin A-Induced Injury of Human Lung Endothelial Cells and IL-8 Accumulation Are Mediated by TNF-{alpha}
J. Immunol., November 15, 1998; 161(10): 5627 - 5632.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J.-M. Thevenin, I. Crandall, S. K. Ballas, I. W. Sherman, and S. B. Shohet
Band 3 Peptides Block the Adherence of Sickle Cells to Endothelial Cells In Vitro
Blood, November 15, 1997; 90(10): 4172 - 4179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. H. Baek, J. K. Seo, C.-B. Chae, P.-G. Suh, and S. H. Ryu
Identification of the Peptides That Stimulate the Phosphoinositide Hydrolysis in Lymphocyte Cell Lines from Peptide Libraries
J. Biol. Chem., April 5, 1996; 271(14): 8170 - 8175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.